InSite Vision Announces Joint Patent Infringement Lawsuit With Merck & Co., Inc. Against Mylan Pharmaceuticals, Inc.

Published: Jun 17, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ALAMEDA, Calif.--(BUSINESS WIRE)--InSite Vision Incorporated (OTCBB:INSV) today announced that it will join Merck (NYSE:MRK), known as MSD outside the United States (U.S.) and Canada, and Pfizer Inc. (NYSE:PFE) in filing a patent infringement lawsuit against Mylan Pharmaceuticals, Inc.

Help employers find you! Check out all the jobs and post your resume.

Back to news